decision of treatment plan

Thanks so much for your prompt response.  Please provide more helpful advice if possible.

My mother is 54, perimenopausal, with a lumpectomy on March 06.  The pathology reports: T1N0M0 0.7 cm IDC with 0.8cm DCIS component. Well modified Bloom & Richardson- Architectural Grade 2, Nuclear Grade 2, Miotic Index 1. Negative margins. SLN-negative nodal involvement. Negative for vascular space invasion. 90% for ER+ and PR+. 3+ for Her 2 neu (Dako). Oncotype DX test score is 17 (with no her2neu mRNA detected). Fish test was inconclusive because of limited tumor sample. However, the pathologist did not see amplification with the nuclei which were available (but fewer than 20 nuclei were able to be examined). My mother's oncologist had put her through radiation therapy (5 weeks) which my mother will complete by the end of this week. Due to the small size of the invasive tumor and being ER/PR+, my mother's oncologist does not recommend my mother for chemo or herceptin.

1.  Will this treatment plan be effective if the tumor is
ER/PR/Her 2+ tumor?  (I am concerned about the use of Zoladex and tamoxifen for ER/PR/Her 2+ tumor from the result of 3+ for her 2 (DAKO) and the Fish test being inconclusive).

2.  Should my mother and I be comfortable with this treatment plan?  

3.Could my mother and I start getting on with life or should we seek a second opinion?

[CCF-RN,MSN-rf]

Dear daughter2: The purpose of this web site is to provide general information and resources that would be helpful to patients and their family members, not to provide specific medical opinions for individuals. If you have concerns or questions that are not being adequately addressed by your physician, a second opinion may be helpful to you.

[Naniam]

The posting by Elainehz is one in which she is trying to prey on us and sell us her "snake oil"  She has posted many of these and it makes me very angry that they come to a BC site and try to make money off our plight.